KEY FINDINGS
The global neurovascular devices / interventional neurology market is projected to grow at a CAGR of 5.08% during the forecast period, 2021-2028. The growing elderly population, prevalence of neurovascular diseases, neurological diseases, and demand for minimally invasive procedures propel the market growth.
MARKET INSIGHTS
Neurovascular devices include coil assist stents, flow diversion stents, embolic coils, clippings, etc. They are used to treat disorders related to blood vessels. For example, the complex forms of aneurysms are treated using coated coils. The growing incidence of neurovascular conditions drives the market growth. Neurovascular systems primarily depend on the continuous supply of oxygen and nutrients carried by veins and arteries. The oxygen and nutrients supply is vital for its working. A defect in the system can hinder its function, thereby becoming a life-threatening factor. Neurovascular conditions, disorders, or diseases include brain aneurysm, brain tumors, vascular malformation, hemorrhage, stroke, etc. The estimated causes of neurovascular diseases are genetic disorders, related chronic diseases, and lifestyle habits.
One of the neurovascular diseases significantly prevalent across the world is the cerebral aneurysm. It is also known as an intracranial aneurysm. It is a bulging area of the brain artery. The bulging further results in abnormal widening. With the presence of a weak spot in the aneurysm wall, there is a risk of rupture of aneurysm bursting. The most common type of cerebral aneurysm is a saccular aneurysm. It occurs in 90% of cerebral aneurysms. However, the lack of an adequate number of trained neurosurgeons and the exorbitant cost of neurovascular devices hamper the market growth.
REGIONAL INSIGHTS
The global neurovascular devices / interventional neurology market growth evaluation includes the analysis of North America, Asia-Pacific, Europe, and Rest of World. North America is the major region in the global market with the rising incidence of neurovascular diseases, surging aging population, and product developments.
COMPETITIVE INSIGHTS
The competitive rivalry is estimated to be high given the growing number of mergers & acquisitions and products launched by major market players. Some prominent market players include Johnson & Johnson (Cerenovus), B Braun Melsungen AG, Integer Holdings Corporation, Microport Scientific Corporation, Acandis GmbH, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
'
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. INCIDENCE OF NEUROVASCULAR CONDITIONS
3.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION
3.1.4. PREVALENCE OF UNDERLYING DISEASE CONDITIONS
3.2. KEY RESTRAINTS
3.2.1. EXORBITANT COST OF NEUROVASCULAR DEVICES
3.2.2. LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. EMBOLIZATION DEVICES
5.1.1. EMBOLIC COILS
5.1.1.1. COATED DETACHABLE COILS
5.1.1.2. BARE DETACHABLE COILS
5.1.2. COIL ASSIST STENT
5.1.3. CLIPPINGS
5.1.4. COIL ASSIST BALLOON
5.2. ACCESSORY DEVICES
5.2.1. MICROCATHETERS
5.2.2. MICRO GUIDEWIRES
5.3. REVASCULARIZATION DEVICES
5.3.1. CAROTID ARTERY STENTS
5.3.2. FLOW DIVERSION STENTS
5.4. THROMBECTOMY DEVICES
5.4.1. CLOT RETRIEVAL DEVICES
5.4.2. SUCTION AND ASPIRATION DEVICES
5.4.3. SNARES
5.5. EMBOLIC PROTECTION DEVICES
5.5.1. BALLOON OCCLUSION DEVICES
5.5.2. DISTAL FILTER DEVICES
6. MARKET BY APPLICATION
6.1. ANEURYSM
6.2. ISCHEMIC STROKE
6.3. STENOSIS
6.4. ARTERIOVENOUS MALFORMATION (AVM)
6.5. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. KEY GROWTH ENABLERS
7.1.3. KEY CHALLENGES
7.1.4. KEY PLAYERS
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. KEY GROWTH ENABLERS
7.2.3. KEY CHALLENGES
7.2.4. KEY PLAYERS
7.2.5. COUNTRY ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. UNITED KINGDOM
7.2.5.3. FRANCE
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. POLAND
7.2.5.7. BELGIUM
7.2.5.8. REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. KEY GROWTH ENABLERS
7.3.3. KEY CHALLENGES
7.3.4. KEY PLAYERS
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. AUSTRALIA & NEW ZEALAND
7.3.5.4. INDIA
7.3.5.5. SOUTH KOREA
7.3.5.6. THAILAND
7.3.5.7. INDONESIA
7.3.5.8. VIETNAM
7.3.5.9. REST OF ASIA-PACIFIC
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. KEY GROWTH ENABLERS
7.4.3. KEY CHALLENGES
7.4.4. KEY PLAYERS
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.2. MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ACANDIS GMBH
8.2.2. ASAHI INTECC
8.2.3. BALT USA LLC
8.2.4. B BRAUN MELSUNGEN AG
8.2.5. INTEGER HOLDINGS CORPORATION
8.2.6. JOHNSON & JOHNSON (CERENOVUS)
8.2.7. KANEKA CORPORATION
8.2.8. MEDTRONIC INC
8.2.9. MEMRY CORPORATION
8.2.10. MICROPORT SCIENTIFIC CORPORATION
8.2.11. PENUMBRA INC
8.2.12. PHENOX GMBH
8.2.13. RAPID MEDICAL
8.2.14. SENSOME
8.2.15. STRYKER CORPORATION
8.2.16. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
1. ACANDIS GMBH
2. ASAHI INTECC
3. BALT
4. B BRAUN MELSUNGEN AG
5. INTEGER HOLDINGS CORPORATION
6. JOHNSON & JOHNSON (CERENOVUS)
7. KANEKA CORPORATION
8. MEDTRONIC INC
9. MEMRY CORPORATION
10. MICROPORT SCIENTIFIC CORPORATION
11. PENUMBRA INC
12. PHENOX GMBH
13. RAPID MEDICAL
14. SENSOME
15. STRYKER CORPORATION
16. TERUMO MEDICAL CORPORATION (MICROVENTION INC)
